Application
KLF13 Antibody (N-term) western blot analysis in U-937 cell line lysates (35ug/lane).This demonstrates the KLF13 antibody detected the KLF13 protein (arrow).| Product Name | KLF13 Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | KLF13; BTEB3; NSLP1; Krueppel-like factor 13; Basic transcription element-binding protein 3; Novel Sp1-like zinc finger transcription factor 1; RANTES factor of late activated T-lymphocytes 1; Transcription factor BTEB3; Transcription factor NSLP1 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | BTEB3 NSLP1 |
|---|---|
| Alternative Names | KLF13 BTEB3 NSLP1 Krueppel-like factor 13 Basic transcription element-binding protein 3 Novel Sp1-like zinc finger transcription factor 1 RANTES factor of late activated T-lymphocytes 1 Transcription factor BTEB3 Transcription factor NSLP1 |
| Molecular Weight(MW) | 31180 Da |
| Function | Represses transcription by binding to the BTE site, a GC-rich DNA element, in competition with the activator SP1. It also represses transcription by interacting with the corepressor Sin3A and HDAC1. Activates RANTES expression in T-cells |
| Tissue Specificity | Ubiquitous. |
| Cellular Localization | Nucleus. |
| Entrez Gene | 51621 |
|---|---|
| Nucleotide Accession | NP_057079.2 |
Application
KLF13 Antibody (N-term) western blot analysis in U-937 cell line lysates (35ug/lane).This demonstrates the KLF13 antibody detected the KLF13 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
